DK383985D0 - Polypeptid - Google Patents

Polypeptid

Info

Publication number
DK383985D0
DK383985D0 DK383985A DK383985A DK383985D0 DK 383985 D0 DK383985 D0 DK 383985D0 DK 383985 A DK383985 A DK 383985A DK 383985 A DK383985 A DK 383985A DK 383985 D0 DK383985 D0 DK 383985D0
Authority
DK
Denmark
Prior art keywords
polypeptide
Prior art date
Application number
DK383985A
Other languages
English (en)
Other versions
DK383985A (da
Inventor
Yoshiaki Kiso
Kazuwa Nakao
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK383985D0 publication Critical patent/DK383985D0/da
Publication of DK383985A publication Critical patent/DK383985A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK383985A 1984-08-24 1985-08-23 Polypeptid DK383985A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59176953A JPH0672155B2 (ja) 1984-08-24 1984-08-24 α−ｈＡＮＰ抗血清作製用ポリペプチド

Publications (2)

Publication Number Publication Date
DK383985D0 true DK383985D0 (da) 1985-08-23
DK383985A DK383985A (da) 1986-02-25

Family

ID=16022607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK383985A DK383985A (da) 1984-08-24 1985-08-23 Polypeptid

Country Status (9)

Country Link
US (1) US4673732A (da)
EP (1) EP0173384B1 (da)
JP (1) JPH0672155B2 (da)
KR (1) KR900006573B1 (da)
CN (1) CN85106564A (da)
CA (1) CA1264900A (da)
DE (1) DE3581336D1 (da)
DK (1) DK383985A (da)
GB (1) GB2164044B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212286A (en) * 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US4804650A (en) * 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
DK175535B1 (da) * 1987-03-04 2004-11-29 Daiichi Suntory Pharma Co Ltd Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid
US4816443A (en) * 1987-05-19 1989-03-28 Merck & Co., Inc. Piptides having ANF activity
JP2873586B2 (ja) * 1988-07-15 1999-03-24 武田薬品工業株式会社 抗体およびこれを用いる免疫化学的測定方法
JPH0667319B2 (ja) * 1989-04-19 1994-08-31 塩野義製薬株式会社 Ａｎｐのｃ端側を認識するモノクローナル抗体
JPH0748071B2 (ja) * 1989-05-31 1995-05-24 株式会社ミドリ十字 ｈＡＮＰ抗体及びｈＡＮＰの免疫学的測定法
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
AT407674B (de) * 1998-09-29 2001-05-25 Biomedica Gmbh Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)
AU2007233123A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
CA2647143A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CN103204923B (zh) * 2013-03-21 2016-06-22 深圳翰宇药业股份有限公司 固相片段法制备卡培立肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
DE3346953A1 (de) * 1983-12-24 1985-08-14 Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
ATE120759T1 (de) * 1984-04-19 1995-04-15 Scios Nova Inc Atrielle natriumuretische/gefässerweiterende polypeptide.
NZ212291A (en) * 1984-06-08 1991-10-25 Suntory Ltd Peptide from human atrium cordis having diuretic action, dna coding therefor and pharmaceutical compositions thereof
EP0166585A3 (en) * 1984-06-22 1987-06-24 Suntory Limited Novel peptide and gene coding for same

Also Published As

Publication number Publication date
KR900006573B1 (ko) 1990-09-13
JPH0672155B2 (ja) 1994-09-14
CA1264900A (en) 1990-01-23
EP0173384A2 (en) 1986-03-05
GB8521137D0 (en) 1985-10-02
CN85106564A (zh) 1987-03-18
EP0173384A3 (en) 1987-12-16
US4673732A (en) 1987-06-16
EP0173384B1 (en) 1991-01-16
JPS6153299A (ja) 1986-03-17
KR870002162A (ko) 1987-03-30
GB2164044B (en) 1988-11-16
DK383985A (da) 1986-02-25
DE3581336D1 (de) 1991-02-21
GB2164044A (en) 1986-03-12

Similar Documents

Publication Publication Date Title
DK496486A (da) Polypeptid
DK151985D0 (da) Humant fysiologisk aktivt polypeptid
NO852173L (no) Rekombinant lymfotoksin.
DK552285A (da) Proteinkonjugat
DK499485A (da) Peptid
DE3786767T2 (de) Neues Polypeptid.
DK184485D0 (da) Mejetaersker
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
DE3579148D1 (de) Polypeptid und polypeptidzusammensetzung.
DK383985A (da) Polypeptid
DK353788A (da) Polypeptidderivater
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
DK256385D0 (da) Interferonpraeparat
ES530597A0 (es) Polipeptido de interferon- humano
DE3582843D1 (de) Vakzinale polypeptide.
FI852866L (fi) Rekombinantfaktor viii-r.
DK86785A (da) Bromcryptinpraeparater
GB8529759D0 (en) Polypeptide
DK51585D0 (da) Proteinkoncentrater
DK8884A (da) Polypeptider
DK596888A (da) Rekombinant lymfotoksin
DK494189D0 (da) Polypeptid
DK624089D0 (da) Polypeptidforbindelser
ATE55414T1 (de) Polypeptid und polypeptidzusammensetzung.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment